MASI 📈 Masimo - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5747951003
MASI: Pulse Oximeters, Patient Monitors, Automation Solutions, Connectivity Platforms
Masimo Corporation is a global leader in the development, manufacturing, and marketing of innovative patient monitoring technologies, as well as automation and connectivity solutions. The company's product portfolio includes a range of technologies designed to improve patient outcomes, such as Masimo Signal Extraction Technology (SET) pulse oximetry, which provides accurate monitoring of oxygen saturation and pulse rate even in challenging conditions like motion or low perfusion. This technology has been shown to address the primary limitations of conventional pulse oximetry, providing healthcare professionals with more reliable and accurate data to inform their decisions.
The Masimo Rainbow SET platform is another key offering from the company, providing noninvasive monitoring of various parameters such as carboxyhemoglobin, methemoglobin, and hemoglobin concentration. This platform also enables the measurement of fractional arterial oxygen saturation, oxygen content, and pleth variability index, among other parameters. Additionally, the company offers acoustic respiration monitoring, SedLine brain function monitoring, and NomoLine capnography and gas monitoring, as well as regional oximetry solutions. These technologies are designed to provide healthcare professionals with a more comprehensive understanding of their patients' conditions, enabling them to make more informed decisions and improve patient outcomes.
Masimo Corporation also provides a range of brain function and hemodynamic monitoring solutions, including patient position and activity tracking, and neuromodulation technology solutions. The company's Masimo Hospital Automation platform offers a suite of hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, and SafetyNet, among others. These solutions are designed to help healthcare providers streamline their workflows, reduce errors, and improve patient safety. The company also offers nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions, further expanding its portfolio of innovative healthcare technologies.
In terms of its business model, Masimo Corporation sells its products through a combination of direct sales force, distributors, and original equipment manufacturer partners. The company's products are used by a range of healthcare providers, including hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and consumers. The company also offers home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. With a strong presence in the global healthcare market, Masimo Corporation is well-positioned to continue innovating and expanding its portfolio of patient monitoring technologies and automation solutions.
Founded in 1989 and headquartered in Irvine, California, Masimo Corporation has established itself as a leading player in the healthcare technology industry. With a web presence at https://www.masimo.com, the company provides easy access to information about its products and services. As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol MASI, Masimo Corporation is committed to transparency and accountability in its operations. With an ISIN of US5747951003 and a classification as a common stock in the Health Care Equipment sub-industry, the company is well-positioned for continued growth and success in the years to come.
Additional Sources for MASI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MASI Stock Overview
Market Cap in USD | 9,238m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2007-08-08 |
MASI Stock Ratings
Growth 5y | -13.7% |
Fundamental | 10.5% |
Dividend | 0.30% |
Rel. Strength Industry | 853 |
Analysts | 4/5 |
Fair Price Momentum | 174.10 USD |
Fair Price DCF | 72.29 USD |
MASI Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 1.0% |
MASI Growth Ratios
Growth Correlation 3m | 93.1% |
Growth Correlation 12m | 34.4% |
Growth Correlation 5y | -70.2% |
CAGR 5y | 1.25% |
CAGR/Mean DD 5y | 0.04 |
Sharpe Ratio 12m | 1.03 |
Alpha | 19.96 |
Beta | 0.89 |
Volatility | 30.78% |
Current Volume | 1105.2k |
Average Volume 20d | 538k |
As of December 21, 2024, the stock is trading at USD 169.52 with a total of 1,105,213 shares traded.
Over the past week, the price has changed by -3.76%, over one month by +2.77%, over three months by +39.61% and over the past year by +49.04%.
Neither. Based on ValueRay Fundamental Analyses, Masimo is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.48 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MASI as of December 2024 is 174.10. This means that MASI is currently overvalued and has a potential downside of 2.7%.
Masimo has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy MASI.
- Strong Buy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, MASI Masimo will be worth about 192.1 in December 2025. The stock is currently trading at 169.52. This means that the stock has a potential upside of +13.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 169 | -0.3% |
Analysts Target Price | 130.6 | -22.9% |
ValueRay Target Price | 192.1 | 13.3% |